vs
Curbline Properties Corp.（CURB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Curbline Properties Corp.的1.3倍（$69.8M vs $54.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 17.6%，领先366.4%）
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CURB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$54.1M
净利率更高
RIGL
高出366.4%
17.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $54.1M | $69.8M |
| 净利润 | $9.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 17.8% | 33.2% |
| 净利率 | 17.6% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.08 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CURBRIGL
| Q4 25 | $54.1M | $69.8M | ||
| Q3 25 | $48.6M | $69.5M | ||
| Q2 25 | $41.4M | $101.7M | ||
| Q1 25 | $38.7M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | $29.8M | $55.3M | ||
| Q2 24 | — | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润CURBRIGL
| Q4 25 | $9.6M | $268.1M | ||
| Q3 25 | $9.4M | $27.9M | ||
| Q2 25 | $10.4M | $59.6M | ||
| Q1 25 | $10.6M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-15.4M | $12.4M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率CURBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CURBRIGL
| Q4 25 | 17.8% | 33.2% | ||
| Q3 25 | 19.3% | 40.9% | ||
| Q2 25 | 25.3% | 60.1% | ||
| Q1 25 | 27.6% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | -51.8% | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率CURBRIGL
| Q4 25 | 17.6% | 384.0% | ||
| Q3 25 | 19.2% | 40.2% | ||
| Q2 25 | 25.1% | 58.6% | ||
| Q1 25 | 27.3% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -51.8% | 22.5% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益（稀释后）CURBRIGL
| Q4 25 | $0.08 | $14.11 | ||
| Q3 25 | $0.09 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.10 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | $-0.15 | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $289.6M | $155.0M |
| 总债务越低越好 | $423.2M | $52.5M |
| 股东权益账面价值 | $1.9B | $391.5M |
| 总资产 | $2.5B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.22× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CURBRIGL
| Q4 25 | $289.6M | $155.0M | ||
| Q3 25 | $430.1M | $137.1M | ||
| Q2 25 | $429.9M | $108.4M | ||
| Q1 25 | $594.0M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | $2.5M | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务CURBRIGL
| Q4 25 | $423.2M | $52.5M | ||
| Q3 25 | $396.4M | $60.0M | ||
| Q2 25 | $99.1M | $60.0M | ||
| Q1 25 | $99.0M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CURBRIGL
| Q4 25 | $1.9B | $391.5M | ||
| Q3 25 | $1.9B | $117.6M | ||
| Q2 25 | $1.9B | $81.9M | ||
| Q1 25 | $1.9B | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $1.1B | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产CURBRIGL
| Q4 25 | $2.5B | $513.6M | ||
| Q3 25 | $2.4B | $242.5M | ||
| Q2 25 | $2.1B | $206.7M | ||
| Q1 25 | $2.1B | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | $1.2B | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比CURBRIGL
| Q4 25 | 0.22× | 0.13× | ||
| Q3 25 | 0.21× | 0.51× | ||
| Q2 25 | 0.05× | 0.73× | ||
| Q1 25 | 0.05× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $124.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.04× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CURBRIGL
| Q4 25 | $124.6M | $22.0M | ||
| Q3 25 | $39.2M | $24.0M | ||
| Q2 25 | $34.2M | $30.5M | ||
| Q1 25 | $25.4M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K | ||
| Q1 24 | — | $-5.0M |
现金转化率CURBRIGL
| Q4 25 | 13.04× | 0.08× | ||
| Q3 25 | 4.19× | 0.86× | ||
| Q2 25 | 3.28× | 0.51× | ||
| Q1 25 | 2.40× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
